'Scout scans' map the way in non-Hodgkin's lymphoma treatment

Links shared publicly online about this topic.

1,111
total visits

'Scout scans' map the way in non-Hodgkin's lymphoma treatment

According to a study presented at SNM's 57th Annual Meeting, molecular imaging can evaluate and optimize non-Hodgkin's lymphoma therapy with Zevalin, a front-line radioimmunotherapy drug that uses a dose of radioactive material and mimics the body's own immune response to target and kill cancer cells ...

View full resource at physorg.com

Tags: Immune, Cancer, Lymphoma, Non-Hodgkin Lymphoma, Drug